STOCK TITAN

OneMedNet Corp - ONMD STOCK NEWS

Welcome to our dedicated page for OneMedNet news (Ticker: ONMD), a resource for investors and traders seeking the latest updates and insights on OneMedNet stock.

OneMedNet Corp (NASDAQ: ONMD) is a forward-thinking healthcare software company that specializes in digital medical image management, exchange, and sharing. Established in 2009, OneMedNet stands as a global provider of clinical imaging innovations and is renowned for its regulatory-grade Imaging Real-World Data (iRWD™). The company's cutting-edge solutions connect healthcare providers and patients, addressing a vital need within the Life Sciences sector by providing direct access to clinical images and associated patient records.

OneMedNet’s flagship offering, the iRWD™ platform, provides secure, comprehensive management of diverse clinical data types, including electronic health records (EHR), laboratory results, and medical imaging data. This platform leverages an extensive federated provider network consisting of over 290 healthcare systems and providers. By employing industry-leading technology and in-house clinical expertise, OneMedNet ensures that its solutions meet the most stringent RWD Life Science requirements.

In recent news, OneMedNet participated in the SCOPE event, which attracted over 4,000 attendees from 850 organizations across 27 countries. During the event, OneMedNet engaged with existing customers and formed new partnerships with Clinical Research Organizations and Life Sciences companies, including Pharma and Medical Device sectors. The company emphasized the importance of expanding patient insight using Real World Data and highlighted its capabilities in providing seamless access to high-quality, de-identified patient data in near real-time.

OneMedNet's impact is far-reaching, with its solutions serving more than 150 million patients each year. The company's commitment to innovation has recently been underscored by securing new customers through globally recognized and trusted channels within the life sciences industry.

For investors, OneMedNet's recent participation in the EF Hutton Annual Global Conference, a premier event in the financial sector, further illustrates its strategic efforts to grow its footprint and engage with key stakeholders in the healthcare and investment communities.

For more information, please visit www.onemednet.com.

Rhea-AI Summary

OneMedNet announced a three-year Master Services Agreement with a top-10 global medical technology company, impacting over 150 million patients annually.

The agreement leverages OneMedNet's iRWD™ platform to securely de-identify, search, and curate regulatory-grade clinical data.

This deal highlights growing industry adoption of OneMedNet's platform and aims to enhance the customer's competitive positioning through better-informed decision-making.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.85%
Tags
none
-
Rhea-AI Summary

OneMedNet announced a significant expansion of its iRWD™ network and platform, boasting a more than five-fold increase.

The company has partnered with new entities, including a nationwide medical records custodian, increasing its network to 1,402 healthcare system and provider partner sites, 31 million patients, and 121.4 million clinical exams.

This growth represents a 472% increase in partner sites, a 170% rise in patients, and a 122% bump in clinical exams since the end of 2023.

CEO Aaron Green emphasized that this expansion aligns with OneMedNet's strategy to leverage real-world data for healthcare innovation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
200%
Tags
none
-
Rhea-AI Summary

OneMedNet , a leading curator of precision curated regulatory-grade Real World Data, will participate in the EF Hutton Annual Global Conference on May 15, 2024. The company's President & CEO and Founder & CMO will be presenting at the event, with management holding one-on-one investor meetings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.07%
Tags
none
Rhea-AI Summary

OneMedNet (Nasdaq: ONMD) has joined ClinEco Inc., a platform that enhances access and distribution for clinical research. This move validates OneMedNet's Real World Data platform within the clinical trial ecosystem. Aaron Green, President and CEO of OneMedNet, expressed excitement at becoming part of this community. ClinEco serves as a networking hub for clinical trial stakeholders, fostering collaboration and innovation in the life sciences sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.75%
Tags
-
Rhea-AI Summary
OneMedNet secures a significant cash infusion of up to $4.54 million through a private placement of senior convertible notes, aiming to bolster its Real World Data platform and accelerate growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.18%
Tags
none
-
Rhea-AI Summary
OneMedNet (ONMD) announces President Aaron Green as the new CEO, succeeding Paul Casey who retires but remains on the board. Green brings over 20 years of experience, driving growth and adding strategic partners, leading to a 15% increase in bookings. The transition reflects successful leadership planning and aims for continued operational momentum.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.18%
Tags
none
Rhea-AI Summary
OneMedNet Corporation (ONMD) partners with a large-scale healthcare system to enhance real-world data availability for life science innovation. The partnership aims to advance new diagnostic and treatment solutions by leveraging regulatory-grade imaging Real World Data (iRWD). This collaboration expands the partner network by 15%, enabling faster and more accurate data delivery to customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
42.17%
Tags
partnership
-
Rhea-AI Summary
OneMedNet Corporation (ONMD) receives positive response at the 15th Annual SCOPE Summit for its regulatory-grade imaging Real World Data solutions. The company aims to collaborate with existing and new partners to enhance patient insight using iRWD.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.18%
Tags
-
Rhea-AI Summary
OneMedNet Corporation (ONMD) announces a growth initiative supporting women's health research, catering to increasing demand from Life Science innovators. The company has a vast regulatory-grade imaging Real World Data database, benefiting patients and organizations. With a focus on women's health issues like cancer, cardiac disease, and Alzheimer's, OneMedNet aims to provide dedicated resources for better understanding and opportunities in this sector.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
none
Rhea-AI Summary
OneMedNet Corporation (Nasdaq: ONMD) will exhibit at the 15th Annual SCOPE Summit for Clinical Ops Executive to showcase its iRWD solution. The company's specialized Real World Data is curated with proprietary AI tools and will be discussed at the Real World Evidence track at the summit.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
168.1%
Tags
none

FAQ

What is the current stock price of OneMedNet (ONMD)?

The current stock price of OneMedNet (ONMD) is $0.682 as of October 17, 2024.

What is the market cap of OneMedNet (ONMD)?

The market cap of OneMedNet (ONMD) is approximately 20.4M.

What is OneMedNet Corp?

OneMedNet Corp is a healthcare software company that specializes in digital medical image management, exchange, and sharing, focusing on regulatory-grade Imaging Real-World Data (iRWD™).

What does OneMedNet's iRWD™ platform do?

The iRWD™ platform provides secure and comprehensive management of diverse clinical data types, including EHR, laboratory results, and medical imaging data, connecting healthcare providers and patients.

How many healthcare systems are part of OneMedNet's network?

OneMedNet's network comprises over 290 healthcare systems and providers.

What recent events has OneMedNet participated in?

OneMedNet recently participated in the SCOPE event and the EF Hutton Annual Global Conference, engaging with key stakeholders and forming new industry partnerships.

How does OneMedNet impact patient care?

OneMedNet's solutions impact more than 150 million patients each year by providing seamless access to de-identified patient data and supporting advanced medical research and clinical trials.

What types of companies partner with OneMedNet?

OneMedNet partners with Clinical Research Organizations, Life Sciences companies, including Pharma and Medical Device sectors.

When was OneMedNet founded?

OneMedNet was founded in 2009.

Who can I contact for investor information?

For investor information, you can contact Shannon Devine or Rory Rumore at MZ Group North America at 203-741-8811 or via email at ONMD@mzgroup.us.

What is OneMedNet’s latest financial achievement?

OneMedNet recently secured a significant cash infusion providing a runway of up to $4.54 million.

Where can I find more information about OneMedNet?

For more information about OneMedNet, please visit their official website at www.onemednet.com.

OneMedNet Corp

Nasdaq:ONMD

ONMD Rankings

ONMD Stock Data

20.35M
33.69M
25.73%
27.48%
1.38%
Health Information Services
Services-commercial Physical & Biological Research
Link
United States of America
SURREY